Hangzhou Meiya Pharmaceutical Co., Ltd.-Industry Trends

News Dynamics

Provides you with the latest company and industry information

Stay up to date with the latest company news and upcoming events

New Pharmacological Insights into Aprotinin: Expanding Perioperative Hemostatic Drug Options

넶0 2026-08-12
New Target for Brain Injury Repair Identified: dBcAMP Delivers Neuroprotection and Cognitive Improvement

넶2 2026-08-05
Pertussis 'Signal Switch': c-di-GMP Regulatory Network May Become a New Anti-infective Target

넶4 2026-07-29
cGMP Pathway: Core Target for Precision Cardiovascular Drug Development

넶6 2026-07-23
Local cAMP Microdomain Mechanism Paves the Way for Precision Anti-Arrhythmia Drugs

넶3 2026-07-17
Stable ATP Levels: A New Strategy to Prevent Neurodegenerative Diseases

넶9 2026-07-08
Regulation of Cryptochromes by FAD Cofactor: New Perspectives for Circadian Rhythm Drug Development

넶9 2026-07-02
Authoritative Research Revises Anti-Aging Industry Consensus: Whole-Blood NAD+ Lacks Value as an Aging Biomarker

넶9 2026-06-25

About Meiya

Product Center

Service Support

Related Links

Address

Headquarters: Hangzhou Meiya Pharmaceutic

al Co., Ltd.

Room 101, Building 12, Yinhai Science and Tech

nology Innovation Center, 501 Fucheng Road,

Xiasha Street, Qiantang District, Hangzhou City,

Zhejiang Province

Sales Company: Shanghai Nucleotide Biotec

hnology Co., Ltd.

Production base: Meiya Pharmaceutical Hai

an Co., Ltd.

Copyright©2025 Hangzhou Meiya Pharmaceutical Co., Ltd.